← Eichor
Study identifier: NCT07668011 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Radial Extracorporeal Shockwave Therapy in Individuals With Iliotibial Band Syndrome

Condition: Iliotibial Band Syndrome  ·  Sponsor: Cairo University

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to 45 Years
Healthy volunteersNo

About this study

The goal of this Clinical Trial Study is to evaluate the clinical effectiveness of Radial Electrocorporeal Shockwave Therapy (rESWT) combined with exercise in individuals with iliotibial band syndrome (ITBS).The main question it aims to answer is : Does the addition of rESWT to standard ITBS exercise program reduce pain intensity and pain pressure threshold while improving lower extremity function and hip muscle strength in Individuals with Iliotibial Band syndrome (ITBS). Participants will be divided into two groups to be compared : The ShamTherapy Group (Control Group) that will receive the standard ITBS exercise program in addition to Sham rESWT, while the experimental group will receive the standard ITBS exercise program in addition to Radial Extracorporeal Shockwave Therapy.

This description comes directly from the study's public registry record.

Talk to the study team

Ahmad El Melhat, PhD  ·  +20 11 12595022  ·  ahmed.elmelhat@cu.edu.lb

Always discuss trial participation with your own doctor first.

Locations (1)

Cairo University HospitalsGiza, Giza Governorate, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07668011